Real-World Effectiveness and Safety of Escalating Once-Weekly Semaglutide from 0.5 to 1.0 mg in Type 2 Diabetes
Metformin: Some research suggests that high doses of metformin can interfere with platelet function, potentially making nosebleeds more frequent or harder to stop
Stress may influence both eating behaviours and gastrointestinal symptoms, making these approaches particularly valuable
Gotta have a good reason, for taking the easy way out Basically, in India, taking the easy way out is much frowned upon
The FLOW trial achieved its primary endpoint with Ozempic 1mg, demonstrating a statistically significant and superior 24% relative risk reduction of kidney disease worsening, kidney failure (end-stage kidney disease), and death due to cardiovascular disease (4.9% absolute risk reduction at three years) compared to placebo, when added to standard of care
Lets settle this once and for all